Bailu Peng

Researcher

University of Arkansas for Medical Sciences

faculty

17 h-index 29 pubs 2,441 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Bailu Peng's research focuses on understanding and developing novel therapeutic strategies for multiple myeloma. Her work investigates the molecular mechanisms underlying the disease, including the role of specific genes and proteins in disease progression and immune evasion. Peng has published research on how CST6 suppresses osteolytic bone disease by blocking osteoclast differentiation, and how high NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma. Additionally, her studies explore the potential of bispecific CAR-T cells targeting both BCMA and CD24 as a treatment approach for multiple myeloma, and how NEK2 inhibition can enhance the efficacy of PD-1/PD-L1 blockade in this cancer. Peng collaborates with researchers at the University of Arkansas for Medical Sciences, including Guido Tricot, John D. Shaughnessy Jr., Fumou Sun, and Frits van Rhee. She has a h-index of 17 and has authored 29 publications with over 2,400 citations.

Metrics

  • h-index: 17
  • Publications: 29
  • Citations: 2,441

Selected Publications

  • High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma (2023) DOI
  • CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation (2022) DOI
  • NEK2 Inhibition Enhances the Efficacy of PD-1/PD-L1 Blockade in Multiple Myeloma (2021) DOI
  • Bispecific CAR-T Cells Targeting Both BCMA and CD24: A Potentially Treatment Approach for Multiple Myeloma (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics